A Pilot Study of BXCL701 in Patients With Pancreatic Cancer
Conditions: Cancer of Pancreas; Cancer of the Pancreas; Neoplasms, Pancreatic; Pancreas Cancer; Pancreatic Cancer Intervention: Drug: Talabostat Mesylate Sponsors: BioXcel Therapeutics Inc; IQVIA Biotech Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Biotechnology | Cancer | Cancer & Oncology | Pancreas | Pancreatic Cancer | Research | Study